Burning Rock Biotech (BNR) Other Operating Expenses: 2019-2025
Historic Other Operating Expenses for Burning Rock Biotech (BNR) over the last 6 years, with Sep 2025 value amounting to $62.3 million.
- Burning Rock Biotech's Other Operating Expenses fell 73.97% to $62.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$61.4 million, marking a year-over-year decrease of 133.49%. This contributed to the annual value of -$30.4 million for FY2024, which is 80.79% up from last year.
- Latest data reveals that Burning Rock Biotech reported Other Operating Expenses of $62.3 million as of Q3 2025, which was up 184.56% from -$73.7 million recorded in Q2 2025.
- Over the past 5 years, Burning Rock Biotech's Other Operating Expenses peaked at $239.3 million during Q3 2024, and registered a low of -$170.4 million during Q4 2021.
- In the last 3 years, Burning Rock Biotech's Other Operating Expenses had a median value of -$40.9 million in 2025 and averaged -$1.9 million.
- Its Other Operating Expenses has fluctuated over the past 5 years, first plummeted by 656.01% in 2022, then spiked by 484.07% in 2024.
- Burning Rock Biotech's Other Operating Expenses (Quarterly) stood at -$170.4 million in 2021, then skyrocketed by 139.11% to $66.6 million in 2022, then crashed by 40.42% to $39.7 million in 2023, then slumped by 122.93% to -$9.1 million in 2024, then plummeted by 73.97% to $62.3 million in 2025.
- Its Other Operating Expenses was $62.3 million in Q3 2025, compared to -$73.7 million in Q2 2025 and -$40.9 million in Q1 2025.